Filtered By:
Management: Healthcare Costs

This page shows you your search results in order of relevance. This is page number 9.

Order by Relevance | Date

Total 274 results found since Jan 2013.

Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatment
Abstract Target specific anticoagulants (TSOACs) have recently been introduced to the US market for multiple indications including venous thromboembolism (VTE) prevention in total hip and knee replacement surgeries, VTE treatment and reduction in the risk of stroke in patients with non-valvular atrial fibrillation (NVAF). Currently, three TSOACs are available including rivaroxaban, apixaban, and dabigatran with edoxaban currently under Food and Drug Administration review for VTE treatment and stroke prevention in NVAF. The introduction of these agents has created a paradigm shift in anticoagulation by considerably...
Source: Journal of Thrombosis and Thrombolysis - January 21, 2015 Category: Hematology Source Type: research

Abstract 221: Outcomes Associated with Warfarin Time in Therapeutic Range Among Nonvalvular Atrial Fibrillation Patients Treated in an Integrated Healthcare Delivery System in the U.S. Session Title: Poster Session II
Conclusions: NVAF patients with low warfarin TTR, in comparison to those with high warfarin TTR, used more healthcare resources resulting in higher healthcare costs.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Deitelzweig, S., Evans, M., Hillson, E., Trocio, J., Bruno, A., Tan, W., Lingohr-Smith, M., Lin, J. Tags: Session Title: Poster Session II Source Type: research

Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data
Conclusions Healthcare costs of CV events are substantial and vary considerably by event type. Incremental costs remain elevated for several years after an event.
Source: The European Journal of Health Economics - June 15, 2015 Category: Health Management Source Type: research

Cardiovascular event costs in patients with Type 2 diabetes mellitus.
CONCLUSIONS: These results illustrate the potential clinical and economic importance of considering patients' CVD risk and medications' cardiovascular safety profile when treating T2DM patients. PMID: 26189723 [PubMed - in process]
Source: Journal of Medical Economics - February 13, 2016 Category: Health Management Tags: J Med Econ Source Type: research

Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Conclusions High risk MI survivors who have been event free for ≥1 year remained at substantial risk of CV events and had increased healthcare costs for up to 5 years post-MI. These long-term risks have not been previously demonstrated in a working-age US population and suggest an unmet need for continuing secondary prevention long-term post-MI. PMID: 26709864 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - February 18, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research

E-045 Product Cost and Utilization in Mechanical Thrombectomy: A Comparison of Techniques
ConclusionA cursory evaluation of the data from this selected subset of patients suggests that there may be no significant difference in overall product cost to the patient for utilization of these two techniques for performance of mechanical thrombectomy. However, upon closer inspection of the data, the cost for aspiration thrombectomy appears to vary quite widely across the subset, with a standard deviation of $22470.99, while the standard deviation for stent retrieval is $2846.91. It is difficult to determine whether this trend would be borne out in a larger sample set; however, it may suggest that product utilization i...
Source: Journal of NeuroInterventional Surgery - July 28, 2016 Category: Neurosurgery Authors: Brown, P., Cobb, M., Smith, T., Zomorodi, A., Gonzalez, L. Tags: Electronic poster abstracts Source Type: research

Abstract 175: Atrial Fibrillation in the USF Resident Clinics: Quality-Driven Medical Therapy Session Title: Poster Session AM
Patients with atrial fibrillation (afib) have a high rate of serious complications including stroke and decompensated heart failure. While patients with afib are five times more likely to suffer a stroke in their lifetime than the general population, this risk can be reduced by 64% with appropriate anticoagulation using warfarin or approved novel oral anticoagulants (NOACs). Reducing the morbidity and mortality from excess strokes is a common interest nationwide due to unsustainable healthcare costs, increasing human resource gaps in medicine, and payment reforms that hold physicians and healthcare organizations financiall...
Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Sadic, E. Tags: Session Title: Poster Session AM Source Type: research

A Novel Deep Neural Network Model for Multi-Label Chronic Disease Prediction
Conclusions concludes this work along with future work. Dataset and Data Preprocessing In the work, we mainly focus on multiple chronic disease classification. It can be formulated into a multi-label classification problem. There are three common chronic diseases are selected from the physical examination records: hypertension (H), diabetes (D), and fatty liver (FL). In the experiments, the physical examination datasets are collected from a local medical center, which contain 110,300 physical examination records from about 80,000 anonymous patients (Li et al., 2017a,b). Sixty-two feature items are selected from over 100...
Source: Frontiers in Genetics - April 23, 2019 Category: Genetics & Stem Cells Source Type: research

Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System
Conclusion: Our findings describe the most reported risk factors for preventability of oral anticoagulant-induced bleedings. These factors may be useful for targeting interventions to improve pharmacovigilance activities in our regional territory and to reduce the burden of medication errors and inappropriate prescription. Introduction Oral anticoagulant therapy is widely used for the prevention of stroke and systemic embolism in patients with atrial fibrillation, or for the prevention and treatment of deep vein thrombosis and pulmonary embolism (Raj et al., 1994; Monaco et al., 2017). Oral anticoagulants can be di...
Source: Frontiers in Pharmacology - April 29, 2019 Category: Drugs & Pharmacology Source Type: research

Diet quality improvement and 30-year population health and economic outcomes: A microsimulation study.
CONCLUSIONS: This microsimulation study suggests that improvements in diet are likely to improve health and economic population outcomes over time. PMID: 33436121 [PubMed - as supplied by publisher]
Source: Public Health Nutrition - January 13, 2021 Category: International Medicine & Public Health Authors: Herman PM, Nguyen P, Sturm R Tags: Public Health Nutr Source Type: research

Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization
CONCLUSION: Patients with PAD who experience major atherothrombotic vascular events post-revascularization have considerably higher healthcare resource use and costs compared with similar metrics pre-revascularization. Therefore, reducing the rate of such events could reduce overall healthcare costs for this population.PMID:33634723 | DOI:10.1080/13696998.2021.1891089
Source: Journal of Medical Economics - February 26, 2021 Category: Health Management Authors: Urvi Desai Akshay Kharat Connie N Hess Dejan Milentijevic Fran çois Laliberté Peter Zuckerman John Benson Patrick Lefebvre William R Hiatt Marc P Bonaca Source Type: research